ReP USP - Resultado da busca

Artigo de periodico
NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia (2021)
Pereira, Daniela A.; Sandrim, Valeria C.; Palei, Ana C.; Amaral, Lorena M.; Belo, Vanessa A.; Lacchini, Riccardo ; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo ; Luizon, Marcelo R.
Source: Pharmacogenomics. Unidades: EERP, FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), CITOCINAS, ÓXIDO NÍTRICO, POLIMORFISMO, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PEREIRA, Daniela A. et al. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, v. 22, n. 8, p. 451-464, 2021Tradução . . Disponível em: https://doi.org/10.2217/pgs-2021-0006. Acesso em: 19 nov. 2024.
APA
Pereira, D. A., Sandrim, V. C., Palei, A. C., Amaral, L. M., Belo, V. A., Lacchini, R., et al. (2021). NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia. Pharmacogenomics, 22( 8), 451-464. doi:10.2217/pgs-2021-0006
NLM
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 19 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Vancouver
Pereira DA, Sandrim VC, Palei AC, Amaral LM, Belo VA, Lacchini R, Cavalli R de C, Tanus-Santos JE, Luizon MR. NAMPT single-nucleotide polymorphism rs1319501 and visfatin/NAMPT affect nitric oxide formation, sFlt-1 and antihypertensive therapy response in preeclampsia [Internet]. Pharmacogenomics. 2021 ; 22( 8): 451-464.[citado 2024 nov. 19 ] Available from: https://doi.org/10.2217/pgs-2021-0006
Artigo de periodico
Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women (2021)
Matheus, Mariana Bertozzi; Pereira, Thaina Omia Bueno; Mattioli, Sarah Viana; Carlström, Mattias; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina
Source: Clinical Biochemistry. Unidade: FMRP
Subjects: PRÉ-ECLÂMPSIA, ÓXIDO NÍTRICO, PRESSÃO SANGUÍNEA, FÁRMACOS (SISTEMA CARDIOVASCULAR)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATHEUS, Mariana Bertozzi et al. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women. Clinical Biochemistry, v. 92, p. 25-33, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.clinbiochem.2021.03.002. Acesso em: 19 nov. 2024.
APA
Matheus, M. B., Pereira, T. O. B., Mattioli, S. V., Carlström, M., Cavalli, R. de C., & Sandrim, V. C. (2021). Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women. Clinical Biochemistry, 92, 25-33. doi:10.1016/j.clinbiochem.2021.03.002
NLM
Matheus MB, Pereira TOB, Mattioli SV, Carlström M, Cavalli R de C, Sandrim VC. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women [Internet]. Clinical Biochemistry. 2021 ; 92 25-33.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2021.03.002
Vancouver
Matheus MB, Pereira TOB, Mattioli SV, Carlström M, Cavalli R de C, Sandrim VC. Different profiles of circulating arginase 2 in subtypes of preeclampsia pregnant women [Internet]. Clinical Biochemistry. 2021 ; 92 25-33.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.clinbiochem.2021.03.002
Artigo de periodico
Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy (2017)
Luizon, Marcelo Rizzatti; Palei, Ana Carolina Taveiros; Belo, V. A.; Amaral, L. M.; Lacchini, Riccardo ; Duarte, Geraldo; Cavalli, Ricardo de Carvalho; Sandrim, Valéria Cristina; Tanus-Santos, José Eduardo
Source: The Pharmacogenomics Journal. Unidades: EERP, FMRP
Subjects: POLIMORFISMO, FÁRMACOS (SISTEMA CARDIOVASCULAR), HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo Rizzatti et al. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, v. 17, n. 5, p. 427-434, 2017Tradução . . Disponível em: https://doi.org/10.1038/tpj.2016.35. Acesso em: 19 nov. 2024.
APA
Luizon, M. R., Palei, A. C. T., Belo, V. A., Amaral, L. M., Lacchini, R., Duarte, G., et al. (2017). Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy. The Pharmacogenomics Journal, 17( 5), 427-434. doi:10.1038/tpj.2016.35
NLM
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/tpj.2016.35
Vancouver
Luizon MR, Palei ACT, Belo VA, Amaral LM, Lacchini R, Duarte G, Cavalli R de C, Sandrim VC, Tanus-Santos JE. Gene-gene interactions in the NAMPT pathway, plasma visfatin/NAMPT levels, and antihypertensive therapy responsiveness in hypertensive disorders of pregnancy [Internet]. The Pharmacogenomics Journal. 2017 ; 17( 5): 427-434.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/tpj.2016.35
Artigo de periodico
Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression (2016)
Luizon, Marcelo R.; Caldeira dias, Mayara; Deffune, Elenice; Fernandes, Karla S.; Cavalli, Ricardo de Carvalho; Tanus-Santos, José Eduardo; Sandrim, Valéria Cristina
Source: Pharmacogenomics. Unidade: FMRP
Subjects: FÁRMACOS (SISTEMA CARDIOVASCULAR), ENDOTÉLIO VASCULAR, EXPRESSÃO GÊNICA, CÉLULAS ENDOTELIAIS, PLASMA, PRÉ-ECLÂMPSIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LUIZON, Marcelo R. et al. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, v. 17, n. 10, p. 1121-1127, 2016Tradução . . Disponível em: https://doi.org/10.2217/pgs-2016-0033. Acesso em: 19 nov. 2024.
APA
Luizon, M. R., Caldeira dias, M., Deffune, E., Fernandes, K. S., Cavalli, R. de C., Tanus-Santos, J. E., & Sandrim, V. C. (2016). Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression. Pharmacogenomics, 17( 10), 1121-1127. doi:10.2217/pgs-2016-0033
NLM
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 nov. 19 ] Available from: https://doi.org/10.2217/pgs-2016-0033
Vancouver
Luizon MR, Caldeira dias M, Deffune E, Fernandes KS, Cavalli R de C, Tanus-Santos JE, Sandrim VC. Antihypertensive therapy in pre-eclampsia: effects of plasma from nonresponsive patients on endothelial gene expression [Internet]. Pharmacogenomics. 2016 ; 17( 10): 1121-1127.[citado 2024 nov. 19 ] Available from: https://doi.org/10.2217/pgs-2016-0033

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em

Non normalized affiliation